Evelo Biosciences, Inc. Soared
Thu, Jul 20, 2023 at 07:28 PM
Evelo Biosciences, Inc. (EVLO:NASDAQ) soared at $9.86, representing a gain of 52.4%. On Thu, Jul 20, 2023, EVLO:NASDAQ touched a New 2-Week High of $9.86. The stock appeared on our News Catalysts scanner on Tue, Jul 18, 2023 at 10:54 AM in the 'BIOTECH' category. From Thu, Jul 06, 2023, the stock recorded 70.00% Up Days and 63.64% Green Days
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- Guardforce AI Co. Limited (GFAI:NASDAQ), 57.46%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 52.4%
- Sirius XM Holdings Inc. (SIRI:NASDAQ), 42.26%
- Priveterra Acquisition Corp. (PMGM:NASDAQ), 41.73%
- PainReform Ltd. (PRFX:NASDAQ), 36.71%
- 22nd Century Group Inc (XXII:NASDAQ), 35.04%
- Inotiv Inc. (NOTV:NASDAQ), 34.52%
- Infobird Co. Ltd (IFBD:NASDAQ), 31.43%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 30.65%